Vaninder Dhillon/hopkinsmedicine.org
Feb 23, 2026, 16:49
Unpacking Genetic Markers for Thyroid Nodule Risks – Johns Hopkins Medicine
Johns Hopkins Medicine shared a post on LinkedIn։
“Is molecular testing in thyroid nodules helpful?
Dr. Vaninder Dhillon breaks down the latest debate from the AAO-HNSF 2025 meeting, exploring how genetic markers are reshaping risk assessment and treatment decisions.”
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 23, 2026, 16:46Marco Zaccaria: Link Between Vaginal Microbiota and Uterine Fibroids Explored
-
Feb 23, 2026, 16:43Yannick Hurni: Comparative Insights on IVF Stimulation Phases
-
Feb 23, 2026, 16:38Ovarian Stroma’s Role in Infertility Treatment Explored – Science Magazine
-
Feb 23, 2026, 16:34FimmCyte and Richter Collaborate on Endometriosis Breakthrough – Startupticker.ch
-
Feb 22, 2026, 17:50New Research on Oocyte Quality Challenges in DOR – RBMO
-
Feb 22, 2026, 06:58Ronell Martz: Fertility Preservation CME with Maria Costantini-Ferrando
-
Feb 22, 2026, 06:25Master Embryo Transfer Techniques at EFRE Conference 2026 – EFRE
-
Feb 22, 2026, 06:11New Insights into Comorbidities in Adenomyosis Patients – RBMO
-
Feb 22, 2026, 06:02New Evidence-Based Recommendations on Infertility – ESHRE